-
1
-
-
79951713554
-
Vadt study group. Blood pressure and cardiovascular disease risk in the veterans affairs diabetes trial
-
Anderson RJ, Bahn GD, Moritz TE, Kaufman D, Abraira C, Duckworth W; VADT Study Group. Blood pressure and cardiovascular disease risk in the Veterans Affairs Diabetes Trial. Diabetes Care 2011;34:34-38.
-
(2011)
Diabetes Care
, vol.34
, pp. 34-38
-
-
Anderson, R.J.1
Bahn, G.D.2
Moritz, T.E.3
Kaufman, D.4
Abraira, C.5
Duckworth, W.6
-
2
-
-
82955226403
-
Veterans affairs diabetes trial (vadt) study group. Observation on renal outcomes in the veterans affairs diabetes trial
-
Agrawal L, Azad N, Emanuele NV, et al.; Veterans Affairs Diabetes Trial (VADT) Study Group. Observation on renal outcomes in the Veterans Affairs Diabetes Trial. Diabetes Care 2011;34: 2090-2094.
-
(2011)
Diabetes Care
, vol.34
, pp. 2090-2094
-
-
Agrawal, L.1
Azad, N.2
Emanuele, N.V.3
-
3
-
-
84884293874
-
Kdigo clinical practice guideline for the management of blood pressure in chronic kidney disease
-
KDIGO Blood Pressure Work Group
-
KDIGO Blood Pressure Work Group. KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int Suppl 2012;2:337-414.
-
(2012)
Kidney Int Suppl
, vol.2
, pp. 337-414
-
-
-
4
-
-
84882244594
-
Blood pressure and mortality in u.s. Veterans with chronic kidney disease: A cohort study
-
Kovesdy CP, Bleyer AJ, Molnar MZ, et al. Blood pressure and mortality in U.S. veterans with chronic kidney disease: a cohort study. Ann Intern Med 2013;159:233-242.
-
(2013)
Ann Intern Med
, vol.159
, pp. 233-242
-
-
Kovesdy, C.P.1
Bleyer, A.J.2
Molnar, M.Z.3
-
5
-
-
84882256638
-
How low can you go? Blood pressure and mortality in chronic kidney disease
-
Rifkin DE, Sarnak MJ. How low can you go? Blood pressure and mortality in chronic kidney disease. Ann Intern Med 2013;159:302-303.
-
(2013)
Ann Intern Med
, vol.159
, pp. 302-303
-
-
Rifkin, D.E.1
Sarnak, M.J.2
-
6
-
-
1642461467
-
Systolic blood pressure, diastolic blood pressure, and pulse pressure: An evaluation of their joint effect on mortality
-
Pastor-Barriuso R, Banegas JR, Damían J, Appel LJ, Guallar E. Systolic blood pressure, diastolic blood pressure, and pulse pressure: an evaluation of their joint effect on mortality. Ann Intern Med 2003;139:731-739.
-
(2003)
Ann Intern Med
, vol.139
, pp. 731-739
-
-
Pastor-Barriuso, R.1
Banegas, J.R.2
Damían, J.3
Appel, L.J.4
Guallar, E.5
-
7
-
-
79954639300
-
Type 2 diabetes strengthens the association between pulse pressure and chronic kidney disease: The aus diab study
-
van den Hurk K, Magliano DJ, Alssema M, et al. Type 2 diabetes strengthens the association between pulse pressure and chronic kidney disease: the Aus Diab study. J Hypertens 2011; 29:953-960.
-
(2011)
J Hypertens
, vol.29
, pp. 953-960
-
-
Van Den Hurk, K.1
Magliano, D.J.2
Alssema, M.3
-
8
-
-
0038460302
-
National heart, lung, and blood institute joint national committee on prevention, detection, evaluation, and treatment of high blood pressure; national high blood pressure education program coordinating committee. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: The jnc 7 report
-
Chobanian AV, Bakris GL, Black HR, et al.; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560-2572.
-
(2003)
JAMA
, vol.289
, pp. 2560-2572
-
-
Chobanian, A.V.1
Bakris, G.L.2
Black, H.R.3
-
9
-
-
84893549987
-
2014 Evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the eighth joint national committee (jnc 8)
-
James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014;311: 507-520.
-
(2014)
JAMA
, vol.311
, pp. 507-520
-
-
James, P.A.1
Oparil, S.2
Carter, B.L.3
-
10
-
-
77951735232
-
Accord study group. Effects of intensive blood-pressure control in type 2 diabetes mellitus
-
Cushman WC, Evans GW, Byington RP, et al.; ACCORD Study Group. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 2010;362:1575-1585.
-
(2010)
N Engl J Med
, vol.362
, pp. 1575-1585
-
-
Cushman, W.C.1
Evans, G.W.2
Byington, R.P.3
-
11
-
-
0032511580
-
Tight blood pressure control and risk of macro vascular and micro vascular complications in type 2 diabetes: Ukpds 38
-
UK Prospective Diabetes Study Group
-
UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macro vascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998;317:703-713.
-
(1998)
BMJ
, vol.317
, pp. 703-713
-
-
-
12
-
-
0032511583
-
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (ukpds 33)
-
UK Prospective Diabetes Study (UKPDS) Group
-
UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-853.
-
(1998)
Lancet
, vol.352
, pp. 837-853
-
-
-
13
-
-
65249111029
-
Advance collaborative group. Lowering blood pressure reduces renal events in type 2 diabetes
-
de Galan BE, Perkovic V, Ninomiya T, et al.; ADVANCE Collaborative Group. Lowering blood pressure reduces renal events in type 2 diabetes. J Am Soc Nephrol 2009;20: 883-892.
-
(2009)
J Am Soc Nephrol
, vol.20
, pp. 883-892
-
-
De Galan, B.E.1
Perkovic, V.2
Ninomiya, T.3
-
14
-
-
79959504988
-
Blood pressure targets in subjects with type 2 diabetesmellitus/impaired fasting glucose: Observations from traditional and bayesian randomeffects meta-analyses of randomized trials
-
810
-
Bangalore S, Kumar S, Lobach I, Messerli FH. Blood pressure targets in subjects with type 2 diabetesmellitus/impaired fasting glucose: observations from traditional and bayesian randomeffects meta-analyses of randomized trials. Circulation 2011;123:2799-2810, 9, 810.
-
(2011)
Circulation
, vol.123
, Issue.9
, pp. 2799-2810
-
-
Bangalore, S.1
Kumar, S.2
Lobach, I.3
Messerli, F.H.4
-
15
-
-
84857786046
-
Accord study group. Combined intensive blood pressure and glycemic control does not produce an additive benefit on micro vascular outcomes in type 2 diabetic patients
-
Ismail-Beigi F, Craven TE, O'Connor PJ, et al.; ACCORD Study Group. Combined intensive blood pressure and glycemic control does not produce an additive benefit on micro vascular outcomes in type 2 diabetic patients. Kidney Int 2012;81:586-594.
-
(2012)
Kidney Int
, vol.81
, pp. 586-594
-
-
Ismail-Beigi, F.1
Craven, T.E.2
O'Connor, P.J.3
-
16
-
-
84892649479
-
Standards of medical care in diabetes 2014
-
American Diabetes Association
-
American Diabetes Association. Standards of medical care in diabetes 2014. Diabetes Care 2014;37(Suppl. 1):S14-S80.
-
(2014)
Diabetes Care
, vol.37
, pp. S14-S80
-
-
-
17
-
-
58149389215
-
Vadt investigators. Glucose control and vascular complications in veterans with type 2 diabetes
-
Duckworth W, Abraira C, Moritz T, et al.; VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009;360:129-139.
-
(2009)
N Engl J Med
, vol.360
, pp. 129-139
-
-
Duckworth, W.1
Abraira, C.2
Moritz, T.3
-
18
-
-
0142199812
-
Va cooperative study of glycemic control and complications in diabetes mellitus type 2. Design of the cooperative study on glycemic control and complications in diabetes mellitus type 2: Veterans affairs diabetes trial
-
Abraira C, Duckworth W, McCarren M, et al.; VA Cooperative Study of Glycemic Control and Complications in Diabetes Mellitus Type 2. Design of the cooperative study on glycemic control and complications in diabetes mellitus type 2: Veterans Affairs Diabetes Trial. J Diabetes Complications 2003;17:314-322.
-
(2003)
J Diabetes Complications
, vol.17
, pp. 314-322
-
-
Abraira, C.1
Duckworth, W.2
McCarren, M.3
-
19
-
-
63149173251
-
Standards of medical care in diabetes 2009
-
American Diabetes Association
-
American Diabetes Association. Standards of medical care in diabetes 2009. Diabetes Care 2009;32(Suppl. 1):S13-S61.
-
(2009)
Diabetes Care
, vol.32
, pp. S13-S61
-
-
-
20
-
-
33747120659
-
Chronic kidney disease epidemiology collaboration. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate
-
Levey AS, Coresh J, Greene T, et al.; Chronic Kidney Disease Epidemiology Collaboration. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006;145:247- 254.
-
(2006)
Ann Intern Med
, vol.145
, pp. 247-254
-
-
Levey, A.S.1
Coresh, J.2
Greene, T.3
-
21
-
-
49149087718
-
Ontarget investigators. Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ontarget study): A multicentre, randomised, double-blind, controlled trial
-
Mann JFE, Schmieder RE, McQueen M, et al.; ONTARGET investigators. Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. Lancet 2008;372:547-553.
-
(2008)
Lancet
, vol.372
, pp. 547-553
-
-
Mann, J.F.E.1
Schmieder, R.E.2
McQueen, M.3
-
22
-
-
84869492851
-
Altitude investigators. Cardiorenal end points in a trial of aliskiren for type 2 diabetes
-
Parving H-H, Brenner BM, McMurray JJ, et al.; ALTITUDE Investigators. Cardiorenal end points in a trial of aliskiren for type 2 diabetes. N Engl J Med 2012;367:2204-2213.
-
(2012)
N Engl J Med
, vol.367
, pp. 2204-2213
-
-
Parving, H.-H.1
Brenner, B.M.2
McMurray, J.J.3
-
23
-
-
84887467090
-
Va nephron-d investigators. Combined angiotensin inhibition for the treatment of diabetic nephropathy
-
Fried LF, Emanuele N, Zhang JH, et al.; VA NEPHRON-D Investigators. Combined angiotensin inhibition for the treatment of diabetic nephropathy. N Engl J Med 2013;369:1892- 1903.
-
(2013)
N Engl J Med
, vol.369
, pp. 1892-1903
-
-
Fried, L.F.1
Emanuele, N.2
Zhang, J.H.3
-
24
-
-
70449360911
-
Advance collaborative group. Combined effects of routine blood pressure lowering and intensive glucose control on macro vascular and micro vascular outcomes in patients with type 2 diabetes: New results from the advance trial
-
Zoungas S, de Galan BE, Ninomiya T, et al.; ADVANCE Collaborative Group. Combined effects of routine blood pressure lowering and intensive glucose control on macro vascular and micro vascular outcomes in patients with type 2 diabetes: new results from the ADVANCE trial. Diabetes Care 2009;32:2068- 2074.
-
(2009)
Diabetes Care
, vol.32
, pp. 2068-2074
-
-
Zoungas, S.1
De Galan, B.E.2
Ninomiya, T.3
|